Skip to search formSkip to main contentSkip to account menu

CY 1503

Known as: CY-1503 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

OligosaccharidesSLeX-OS

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2007
Review
2007
Targeting leukocyte trafficking to inflamed skin – still an attractive therapeutic approach?
Abstract:  Research into leukocyte trafficking and its therapeutic exploitation appears to be a multistep process, just like the… 
Highly Cited
2000
Highly Cited
2000
The use of cylexin (CY-1503) in prevention of reperfusion lung injury in patients undergoing pulmonary thromboendarterectomy.
Pulmonary thromboendartectomy (PTE) for chronic thromboembolic pulmonary hypertension may be complicated by reperfusion lung… 
2000
2000
Sialyl LewisX oligosaccharide preserves myocardial and endothelial function during cardioplegic ischemia.
1999
1999
A novel sialyl Lewis X analog attenuates cerebral injury after deep hypothermic circulatory arrest.
1999
1999
Selectin blockade reduces neutrophil interaction with platelets at the site of deep arterial injury by angioplasty in pigs.
The adhesion of neutrophils to damaged arterial surfaces is increased in the presence of platelets by a mechanism implicating… 
1997
1997
Carbohydrate selectin inhibitor CY-1503 reduces neutrophil migration and reperfusion injury in canine pulmonary allografts.
BACKGROUND Neutrophil adhesion is initiated by the interaction of rapidly expressed endothelial selectins with oligosaccharide… 
1997
1997
Protective role of synthetic sialylated oligosaccharide in sepsis-induced acute lung injury.
Proper engagement of leukocyte and endothelial cell selectins with their counterreceptors is an initial step in neutrophil… 
Highly Cited
1996
Highly Cited
1996
E-Selectin in Focal Cerebral Ischemia and Reperfusion in the Rat
The selectin family of glycoproteins facilitates the early phase of polymorphonuclear leukocyte adhesion to the endothelial cell… 
1996
1996
An oligosaccharide sialyl-Lewis(x) analogue does not reduce myocardial infarct size after ischemia and reperfusion in dogs.
BACKGROUND Polymorphonuclear leukocytes, particularly neutrophils, are important mediators of ischemia/reperfusion-induced… 
Highly Cited
1994
Highly Cited
1994
A novel sialyl LewisX analog attenuates neutrophil accumulation and myocardial necrosis after ischemia and reperfusion.
BACKGROUND Polymorphonuclear leukocytes (PMNs) have been shown to mediate coronary vascular and myocardial tissue injury after… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)